Abiopharma

🔍 Palmieri Jane (Director)

Company: STANLEY BLACK & DECKER, INC. (SWK)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 122 shares of Common Stock at $70.77 per share (Direct)
  Date: 2026-03-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,550.27 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25 shares of Deferred Shares (Derivative)
  Date: 2026-03-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,126.53 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Under the Stanley Black & Decker, Inc. 2020 Restricted Stock Unit Deferral Plan for Non-Employee Directors (the "RSU Deferral Plan"), each director's account is credited with dividend equivalents on the deferred restricted stock units when the Company pays cash dividends on its common stock (including special dividends, if any), and such dividend equivalents are denominated in additional restricted stock units based on the average of the high and low price per share on the New York Stock Exchange on the payment date applicable to such dividend. The number of shares reflects the credit of such dividend equivalents to the reporting person's account under the RSU Deferral Plan, which will be settled in accordance with the deferral election made by the reporting person applicable to the underlying deferred restricted stock units.
• F2: Represents additional deferred shares acquired through the reinvestment of dividends paid on deferred shares credited to the reporting person's account under the Stanley Black & Decker, Inc. Deferred Compensation Plan for Non-Employee Directors (the "Deferred Compensation Plan"). Each deferred share entitles the holder thereof to receive one share of common stock upon settlement. The deferred shares credited to the reporting person's account under the Deferred Compensation Plan, including any additional deferred shares acquired through dividend reinvestment, will be settled in one lump sum payment of common stock on March 1 immediately following the date on which the reporting person ceases to be a member of the Board of Directors.